224 related articles for article (PubMed ID: 10632332)
1. Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatocellular carcinoma.
Kondo M; Yamamoto H; Nagano H; Okami J; Ito Y; Shimizu J; Eguchi H; Miyamoto A; Dono K; Umeshita K; Matsuura N; Wakasa K; Nakamori S; Sakon M; Monden M
Clin Cancer Res; 1999 Dec; 5(12):4005-12. PubMed ID: 10632332
[TBL] [Abstract][Full Text] [Related]
2. Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation.
Koga H; Sakisaka S; Ohishi M; Kawaguchi T; Taniguchi E; Sasatomi K; Harada M; Kusaba T; Tanaka M; Kimura R; Nakashima Y; Nakashima O; Kojiro M; Kurohiji T; Sata M
Hepatology; 1999 Mar; 29(3):688-96. PubMed ID: 10051469
[TBL] [Abstract][Full Text] [Related]
3. The correlation between cyclooxygenase-2 expression and hepatocellular carcinogenesis.
Sung YK; Hwang SY; Kim JO; Bae HI; Kim JC; Kim MK
Mol Cells; 2004 Feb; 17(1):35-8. PubMed ID: 15055524
[TBL] [Abstract][Full Text] [Related]
4. Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398.
Bae SH; Jung ES; Park YM; Kim BS; Kim BK; Kim DG; Ryu WS
Clin Cancer Res; 2001 May; 7(5):1410-8. PubMed ID: 11350912
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis B virus-associated hepatocellular carcinoma.
Cheng AS; Chan HL; To KF; Leung WK; Chan KK; Liew CT; Sung JJ
Int J Oncol; 2004 Apr; 24(4):853-60. PubMed ID: 15010822
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2 expression in hepatocellular carcinoma.
Shiota G; Okubo M; Noumi T; Noguchi N; Oyama K; Takano Y; Yashima K; Kishimoto Y; Kawasaki H
Hepatogastroenterology; 1999; 46(25):407-12. PubMed ID: 10228831
[TBL] [Abstract][Full Text] [Related]
7. Overexpressed cyclo-oxygenase-2 in the background liver is associated with the clinical course of hepatitis C virus-related cirrhosis patients after curative surgery for hepatocellular carcinoma.
Morinaga S; Tarao K; Yamamoto Y; Nakamura Y; Rino Y; Miyakawa K; Ohkawa S; Akaike M; Sugimasa Y; Takemiya S
J Gastroenterol Hepatol; 2007 Aug; 22(8):1249-55. PubMed ID: 17688665
[TBL] [Abstract][Full Text] [Related]
8. Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH
Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832
[TBL] [Abstract][Full Text] [Related]
9. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
Lee MJ; Yu GR; Park SH; Cho BH; Ahn JS; Park HJ; Song EY; Kim DG
Clin Cancer Res; 2008 Feb; 14(4):1080-9. PubMed ID: 18281540
[TBL] [Abstract][Full Text] [Related]
10. Correspondence re: M. Kondo et al., Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatocellular carcinoma. Clin. Cancer Res., 5: 4005-4012, 1999.
Utsunomiya T; Shimada M; Rikimaru T; Sugimachi K; Ohkura KI; Kaku S; Yamada K; Taguchi KI
Clin Cancer Res; 2000 Dec; 6(12):4965-6. PubMed ID: 11156258
[No Abstract] [Full Text] [Related]
11. Reduction of dihydrodiol dehydrogenase expression in resected hepatocellular carcinoma.
Yang MD; Wu CC; Chiou SH; Chiu CF; Lin TY; Chiang IP; Chow KC
Oncol Rep; 2003; 10(2):271-6. PubMed ID: 12579257
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of cyclooxygenase-2 and increased infiltration of regulatory T cells in tumors of patients with hepatocellular carcinoma.
Gao YW; Chen YX; Wang ZM; Jin J; Li XY; Zhou le D; Huo Z; Zhou JH; Chen W
Digestion; 2009; 79(3):169-76. PubMed ID: 19329856
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
Half E; Tang XM; Gwyn K; Sahin A; Wathen K; Sinicrope FA
Cancer Res; 2002 Mar; 62(6):1676-81. PubMed ID: 11912139
[TBL] [Abstract][Full Text] [Related]
14. [Expression of cyclooxygenase-2 in human transitional cell bladder carcinomas].
Zhan J; Tang XD
Ai Zheng; 2002 Nov; 21(11):1212-6. PubMed ID: 12526218
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of Wiskott-Aldrich syndrome protein family verprolin-homologous protein 2 correlated with poor prognosis of hepatocellular carcinoma.
Yang LY; Tao YM; Ou DP; Wang W; Chang ZG; Wu F
Clin Cancer Res; 2006 Oct; 12(19):5673-9. PubMed ID: 17020969
[TBL] [Abstract][Full Text] [Related]
16. Expression of Aurora B and alternative variant forms in hepatocellular carcinoma and adjacent tissue.
Yasen M; Mizushima H; Mogushi K; Obulhasim G; Miyaguchi K; Inoue K; Nakahara I; Ohta T; Aihara A; Tanaka S; Arii S; Tanaka H
Cancer Sci; 2009 Mar; 100(3):472-80. PubMed ID: 19134008
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma.
Ikeguchi M; Hirooka Y; Kaibara N
Cancer; 2002 Nov; 95(9):1938-45. PubMed ID: 12404288
[TBL] [Abstract][Full Text] [Related]
18. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.
Masaki T; Tokuda M; Yoshida S; Nakai S; Morishita A; Uchida N; Funaki T; Kita Y; Funakoshi F; Nonomura T; Himoto T; Deguchi A; Kimura Y; Izuishi K; Wakabayashi H; Usuki H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
Int J Oncol; 2005 Mar; 26(3):661-71. PubMed ID: 15703821
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of cyclooxygenase-2 in carcinoma of the pancreas.
Okami J; Yamamoto H; Fujiwara Y; Tsujie M; Kondo M; Noura S; Oshima S; Nagano H; Dono K; Umeshita K; Ishikawa O; Sakon M; Matsuura N; Nakamori S; Monden M
Clin Cancer Res; 1999 Aug; 5(8):2018-24. PubMed ID: 10473081
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of transient receptor potential vanilloid 2 expression in human hepatocellular carcinoma.
Liu G; Xie C; Sun F; Xu X; Yang Y; Zhang T; Deng Y; Wang D; Huang Z; Yang L; Huang S; Wang Q; Liu G; Zhong D; Miao X
Cancer Genet Cytogenet; 2010 Feb; 197(1):54-9. PubMed ID: 20113837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]